US Broker Ratings

Revvity, Inc. (RVTY) Investor Outlook: Analysts See 16.72% Upside Potential

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, operates within the diagnostics and research industry, offering a suite of health sciences solutions. With..

Novartis AG (NVS) Stock Analysis: Revenue Growth Shines Amidst Mixed Analyst Ratings

Novartis AG (NYSE: NVS), a titan in the healthcare sector, continues to be a focal point for investors seeking stability and growth in the pharmaceutical industry...

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 15.73% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, is a Japanese multinational corporation that specializes in the research, development, and manufacture of..

Boston Scientific Corporation (BSX) Stock Analysis: Healthcare Giant with 16.66% Upside Potential

Boston Scientific Corporation (BSX), a prominent player in the healthcare sector, particularly in medical devices, continues to capture investor interest with a robust market cap of..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating a Healthcare Powerhouse with 18% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA), a leading player in the medical care facilities industry, commands significant attention from investors as it stands at the intersection of..

ICON plc (ICLR) Stock Analysis: Navigating the Healthcare Sector with a 13.79% Potential Upside

ICON plc (NASDAQ: ICLR), a leading clinical research organization headquartered in Dublin, Ireland, has captured the attention of investors with its robust strategic offerings in the..

Exact Sciences Corporation (EXAS) Investor Outlook: High Growth Potential with 41% Upside

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, has caught the attention of investors with..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 6.14% Upside Potential in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a dominant player in the healthcare sector, particularly in medical distribution, is attracting investor attention with a market cap of $8.93..

Humana Inc. (HUM) Stock Analysis: Exploring a 19.91% Potential Upside Amid Strong Revenue Growth

Investors looking to explore opportunities within the healthcare sector may find Humana Inc. (NYSE: HUM) a compelling prospect. As a well-established player in the healthcare plans..

DexCom, Inc. (DXCM) Stock Analysis: Unpacking the 11.65% Upside Potential for Investors

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the healthcare sector, specializes in the medical devices industry, focusing on continuous glucose monitoring (CGM) systems. With a..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Navigating Challenges with an 8.61% Dividend Yield

Investors eyeing Walgreens Boots Alliance, Inc. (NASDAQ: WBA) are presented with a complex picture. As a major player in the healthcare sector, specifically within the pharmaceutical..

McKesson Corporation (MCK) Investor Outlook: Navigating a 9.40% Upside Potential

McKesson Corporation (NYSE: MCK), an integral player in the healthcare sector, exemplifies resilience and adaptability in the ever-evolving landscape of medical distribution. With a market capitalization..

Investor Outlook: The Cooper Companies, Inc. (COO) Shows 25% Potential Upside Amid Solid Buy Ratings

Investors seeking opportunities in the healthcare sector might find The Cooper Companies, Inc. (NYSE: COO) intriguing, as it offers a compelling investment case with a notable..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with a 30% Revenue Growth Surge

Exelixis, Inc. (NASDAQ: EXEL), a notable player in the biotechnology sector, continues to capture investor attention with its remarkable revenue growth of 30.60%. The company, headquartered..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 6.36% Potential Upside for Investors

Edwards Lifesciences Corporation (NYSE: EW), a leading name in the healthcare sector, presents an intriguing opportunity for investors with a 6.36% potential upside. As a key..

Insulet Corporation (PODD) Stock Analysis: Strong Buy Ratings Highlight 17.2% Potential Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector specializing in medical devices, is capturing significant attention in the investment community. With a market..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Veeva Systems Inc. (NYSE: VEEV), a leader in providing cloud-based software solutions tailored for the life sciences sector, is capturing attention with its strategic growth trajectory..

Genmab A/S (GMAB) Stock Analysis: A 31% Upside Potential in the Biotech Sector

Genmab A/S (GMAB), a prominent player in the biotechnology sector, stands out with its robust portfolio of antibody-based products targeting cancer and other serious diseases. Headquartered..

Encompass Health Corporation (EHC) Stock Analysis: 22% Upside Potential and Robust Revenue Growth

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, shines in the medical care facilities industry with a market capitalization of $10.85 billion...

Royalty Pharma plc (RPRX) Stock Analysis: A 14.94% Potential Upside Beckons Investors

Royalty Pharma plc (NASDAQ: RPRX) represents a unique opportunity in the biotechnology sector for investors seeking exposure to the healthcare industry with a focus on biopharmaceutical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds